On the recordJuly 28, 2021
Finally, there needs to be clarity and transparency about the standards for approval for deadly diseases with unmet medical needs.
Source
congress.govEditor's note · Context
Eshoo stresses the importance of clear approval standards for critical diseases.
Share
More from Anna Eshoo
Apr 25, 2023
The PBM Accountability Act will finally shed a light on the opaque drug pricing system.
Dec 10, 2024
I rise this evening to give valedictory remarks as my service as a United States Representative comes to a close. Nearly 32 years ago, I arrived in this Chamber after the people of the most distinguished congressional district in our…
Apr 18, 2023
I support the legislation we are considering today to permanently authorize the THC GME program and fund new training sites to increase resident physician spots.
May 22, 2023
I've long been a champion for protecting vulnerable communities from the harms that come with new technologies.
Other voices in this conversation
